COMMUNITY HEALTH SYSTEMS INC·4

Mar 3, 4:32 PM ET

Brooks Susan W 4

Research Summary

AI-generated summary

Updated

Community Health Systems (CYH) Director Susan Brooks Exercises, Receives RSUs

What Happened

  • Susan W. Brooks, a director of Community Health Systems (CYH), reported exercise/conversion of derivative securities into common stock and a new restricted stock unit (RSU) grant.
  • On 2026-03-01 she converted/exercised three derivative tranches totaling 50,595 shares (9,756; 20,906; 19,933) at $0 per share, and the filing also shows same-day derivative dispositions of those same amounts at $0. On the same date she was granted 52,023 RSUs (reported as an acquisition at $0).
  • Total values are reported at $0 per share in the filing (conversion/grant priced at $0). The RSU grant is the principal new economic interest reported.

Key Details

  • Transaction date: 2026-03-01; Form 4 filed 2026-03-03 (timely filing).
  • Conversions/exercises: 9,756; 20,906; 19,933 shares (total 50,595) — all reported at $0. Matching derivative dispositions of the same amounts also reported at $0 on the same day.
  • Grant: 52,023 restricted stock units (RSUs) reported as acquired at $0.
  • Shares owned after transaction: not specified in the provided excerpt of the filing; see the full Form 4 for post-transaction holdings.
  • Footnotes: F1 — converted securities convert to common stock on a one-for-one basis. F2 — the 52,023 RSUs vest in 1/3 increments on the first, second and third anniversaries of the grant and will be settled one-for-one in common stock upon vesting.
  • Filing timeliness: Filed within two days of the report date (not indicated as late).

Context

  • The filing shows conversion/exercise of derivative instruments followed by same-day derivative dispositions (both at $0). Same-day disposition of converted shares can reflect immediate sale, net settlement, or other non-open-market transfers — the Form 4 does not specify the economic reason.
  • The material new economic detail here is the 52,023 RSU grant, which vests over three years per the footnote; grants are informative about expected future stock-based compensation but do not by themselves indicate the director’s market view.